BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33859989)

  • 1. Relationships of the Trace Elements Zinc and Magnesium With Diabetic Nephropathy-Associated Renal Functional Damage in Patients With Type 2 Diabetes Mellitus.
    Feng J; Wang H; Jing Z; Wang Y; Wang W; Jiang Y; Sun W
    Front Med (Lausanne); 2021; 8():626909. PubMed ID: 33859989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated miRNA-375, IL-17, TGF-β, and Microminerals Are Associated with Calpain-10 SNP 19 in Diabetic Patients: Correlation with Diabetic Nephropathy Stages.
    Ezzat GM; Azoz NMA; El Zohne RA; Abdellatif H; Saleem TH; Emam WA; Mohammed AR; Mohamed SA; Muhammed AA; Abd El-Rady NM; Hamdy M; Sherkawy HS; Sabet MA; Seif Eldin S; Dahpy MA
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between serum interleukin-1 beta and heparin sulphate in diabetic nephropathy patients.
    Jiang L; Zhou J; Zhang L; Du Y; Jiang M; Xie L; Ma Z; Chen F
    Glycoconj J; 2021 Dec; 38(6):697-707. PubMed ID: 34997893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum TNF-α concentrations in type 2 diabetes mellitus patients and diabetic nephropathy patients: A systematic review and meta-analysis.
    Chen YL; Qiao YC; Xu Y; Ling W; Pan YH; Huang YC; Geng LJ; Zhao HL; Zhang XX
    Immunol Lett; 2017 Jun; 186():52-58. PubMed ID: 28414180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-α and IL-1β Promote Renal Podocyte Injury in T2DM Rats by Decreasing Glomerular VEGF/eNOS Expression Levels and Altering Hemodynamic Parameters.
    Wang J; Feng Y; Zhang Y; Liu J; Gong L; Zhang X; Liao H
    J Inflamm Res; 2022; 15():6657-6673. PubMed ID: 36532651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Serum Nampt Levels and Its Significances in Diabetic Nephropathy Patients-The Potential Role of Nampt in T2DM with Diabetic Nephropathy.
    Ma X; An L; Wang Q
    Endocr Metab Immune Disord Drug Targets; 2017; 17(2):114-124. PubMed ID: 28699485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression.
    Hameed I; Masoodi SR; Malik PA; Mir SA; Ghazanfar K; Ganai BA
    Gene; 2018 Jun; 661():51-59. PubMed ID: 29605608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences and Clinical Significance of Serum 25-Hydroxyvitamin D3 and Vasohibin-1 (VASH-1) Levels in Patients with Diabetic Nephropathy and Different Renal Injuries.
    Liu H; Wang D; Tang J; Yu L; Su S
    Diabetes Metab Syndr Obes; 2023; 16():1085-1091. PubMed ID: 37155499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
    Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
    Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant activation profile of cytokines and mitogen-activated protein kinases in type 2 diabetic patients with nephropathy.
    Wong CK; Ho AW; Tong PC; Yeung CY; Kong AP; Lun SW; Chan JC; Lam CW
    Clin Exp Immunol; 2007 Jul; 149(1):123-31. PubMed ID: 17425653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal pro-inflammatory cytokine gene expression in diabetic nephropathy: effect of angiotensin-converting enzyme inhibition and pentoxifylline administration.
    Navarro JF; Milena FJ; Mora C; León C; García J
    Am J Nephrol; 2006; 26(6):562-70. PubMed ID: 17167242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3a receptor antagonist ameliorates inflammatory and fibrotic signals in type 2 diabetic nephropathy by suppressing the activation of TGF-β/smad3 and IKBα pathway.
    Li L; Yin Q; Tang X; Bai L; Zhang J; Gou S; Zhu H; Cheng J; Fu P; Liu F
    PLoS One; 2014; 9(11):e113639. PubMed ID: 25422985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison Between Biomarkers of Kidney Injury, Inflammation, and Oxidative Stress in Patients with Diabetic Nephropathy and Type 2 Diabetes Mellitus.
    Aghadavod E; Soleimani A; Amirani E; Gholriz Khatami P; Akasheh N; Sharafati Chaleshtori R; Shafabakhsh R; Banikazemi Z; Asemi Z
    Iran J Kidney Dis; 2020 Jan; 14(1):31-35. PubMed ID: 32156839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in
    Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
    Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between inflammation, endothelial dysfunction and proteinuria in patients with diabetic nephropathy.
    Taslipinar A; Yaman H; Yilmaz MI; Demirbas S; Saglam M; Taslipinar MY; Agilli M; Kurt YG; Sonmez A; Azal O; Bolu E; Yenicesu M; Kutlu M
    Scand J Clin Lab Invest; 2011 Nov; 71(7):606-12. PubMed ID: 21864054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of reactive aldehydes in urine and plasma of type-2 diabetes mellitus patients through liquid chromatography-mass spectrometry: Reactive aldehydes as potential markers of diabetic nephropathy.
    Harkin C; Cobice D; Watt J; Kurth MJ; Brockbank S; Bolton S; Johnston F; Strzelecka A; Lamont JV; Moore T; Fitzgerald P; Ruddock MW
    Front Nutr; 2022; 9():997015. PubMed ID: 36726822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy.
    Kung WJ; Lin CC; Liu SH; Chaung HC
    Diabetes Technol Ther; 2010 Oct; 12(10):809-13. PubMed ID: 20809684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
    Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
    Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus.
    Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y
    Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.